Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [
Amyloid imaging
Dementia
Positron emission tomography
[11C]PIB
[18F]FDG
Journal
European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
06
04
2018
accepted:
10
07
2018
pubmed:
11
8
2018
medline:
8
5
2019
entrez:
11
8
2018
Statut:
ppublish
Résumé
Cerebral beta-amyloid and regional glucose metabolism assessed by positron emission tomography (PET) are used as diagnostic biomarkers for Alzheimer's disease (AD). The present study validates the incremental diagnostic value of amyloid PET in addition to clinical diagnosis and [ Of 138 consecutive patients with cognitive impairment who received combined [ After disclosure of the amyloid PET results, clinical and [ Amyloid PET provides significant incremental diagnostic value beyond clinical and [
Identifiants
pubmed: 30094462
doi: 10.1007/s00259-018-4111-3
pii: 10.1007/s00259-018-4111-3
pmc: PMC6333717
doi:
Substances chimiques
Amyloid
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
312-323Références
Arch Neurol. 1999 Mar;56(3):303-8
pubmed: 10190820
Neurology. 2005 Dec 27;65(12):1863-72
pubmed: 16237129
Neurology. 2006 Feb 14;66(3):331-8
pubmed: 16476930
Nat Clin Pract Neurol. 2006 Jul;2(7):375-81
pubmed: 16932588
J Nucl Med. 2007 Dec;48(12):1961-70
pubmed: 18006622
Arch Neurol. 2010 Dec;67(12):1506-12
pubmed: 21149812
Neurology. 2011 Mar 15;76(11):1006-14
pubmed: 21325651
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Brain. 2011 Sep;134(Pt 9):2456-77
pubmed: 21810890
J Nucl Med. 2012 Jan;53(1):59-71
pubmed: 22173840
J Neuropathol Exp Neurol. 2012 Apr;71(4):266-73
pubmed: 22437338
Alzheimers Dement. 2013 Jul;9(4):414-21
pubmed: 23164552
Alzheimer Dis Assoc Disord. 2013 Jan-Mar;27(1):4-15
pubmed: 23203162
Dement Geriatr Cogn Dis Extra. 2012 Jan;2(1):610-21
pubmed: 23341826
J Nucl Med. 2013 Mar;54(3):476-90
pubmed: 23359661
Neurology. 2013 Jul 30;81(5):487-500
pubmed: 23897875
Neurology. 2014 Jan 21;82(3):230-8
pubmed: 24353340
J Alzheimers Dis. 2014;42(1):169-82
pubmed: 24840572
JAMA. 2015 May 19;313(19):1939-49
pubmed: 25988463
Brain. 2015 Oct;138(Pt 10):3089-99
pubmed: 26280595
Dement Geriatr Cogn Disord. 2016;41(1-2):80-92
pubmed: 26745445
J Alzheimers Dis. 2016 Apr 18;52(4):1251-62
pubmed: 27104896
JAMA Neurol. 2016 Dec 1;73(12):1417-1424
pubmed: 27802513
Alzheimers Dement (Amst). 2016 Dec 18;5:15-22
pubmed: 28054024
Alzheimers Res Ther. 2017 Jan 17;9(1):2
pubmed: 28093088
Dement Geriatr Cogn Disord. 2017;44(3-4):129-143
pubmed: 28787712
Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2239-2248
pubmed: 28932894
J Neurol Neurosurg Psychiatry. 2018 Mar;89(3):294-299
pubmed: 29018162
Alzheimers Dement. 2018 Mar;14(3):293-305
pubmed: 29107051
Neurology. 1984 Jul;34(7):939-44
pubmed: 6610841
J Nucl Med. 1995 Jul;36(7):1238-48
pubmed: 7790950
Neurology. 1994 Jul;44(7):1240-5
pubmed: 8035923
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571